<DOC>
	<DOCNO>NCT01517997</DOCNO>
	<brief_summary>In total 50 patient diagnose long-segment infrapopliteal arterial disease randomize two group . The patient randomize Drug coat balloon ( DCB ) study arm undergo percutaneous transluminal angioplasty ( PTA ) use paclitaxel-coated balloon , patient randomize drug-eluting stent ( DES ) study arm undergo primary stenting use drug-eluting stent ( ) . The study 's primary endpoint 6-month angiographic binary restenosis rate . Secondary endpoint include immediate technical success,6-month primary patency , target lesion revascularization limb salvage complication rate .</brief_summary>
	<brief_title>Infrapopliteal Drug Eluting Angioplasty Versus Stenting</brief_title>
	<detailed_description>Patients program undergo PTA due angiographically-proven infrapopliteal arterial disease department randomize mention study arm . The study primary endpoint assess use intra-arterial digital subtract angiography subsequent Quantitative Vascular Analysis ( QVA ) analysis.Clinical follow-up set 1 , 3 6 month . Patients ' baseline demographic procedural detail record analyze .</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Angiographically document infrapopliteal disease . Rutherford category peripheral arterial disease class 3 6 Lesion length 70 220 mm Lesions situate proximal , mid mid distal segment tibial vessel . Lesion length &lt; 70 mm &gt; 220 mm . Lesions situate distal third tibial vessel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Drug coat balloon</keyword>
	<keyword>Drug elute stent</keyword>
</DOC>